20 (AIDX) Cash from Investing Activities (2026)
20's (AIDX) quarterly Cash from Investing Activities came in at -$5354.0 in Q1 2026.
20 (AIDX) Cash from Investing Activities (2026) Analysis & Trends
20 (AIDX) has 1 years of Cash from Investing Activities data on file, last reported at -$5354.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -108.50 Mn |
| 10 | 20 | 5.56 Mn | 1.01 Mn | 304,727.00 | -7,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,354.00 |
| Mar 31, 2026 | -5,354.00 |